Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Way to go AFT Pharmaceuticals - everyone should try these products and every pharmacy should offer these to your patients
Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study
Great product great service
Hiromichi Wakui has received research supports from AstraZeneca, Otsuka Pharmaceutical, and Kaneka Corporation, and honoraria from AstraZeneca, Otsuka Pharmaceutical, Kaneka Corporation, Kyowa Kirin, Sanwa Kagaku, Chugai Pharma, Kowa, Otsuka Pharmaceutical, Novartes, Mitsubishi-Tanabe Pharma, Bayer, and Daiichi-Sankyo Pharma
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
US$ 22.05
US$ 29.12
US$ 20.28
